RPL34 and central nervous system cancer: To confirm whether the contribution of RPL34-AS1 to glioma development was mediated through the ERK/AKT signaling pathway, we assessed the expression of ERK, AKT, p-ERK, and p-AKT by western blot (Figure 4A, 4B).